This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BSD Medical Obtains Marketing Approval In Russian Federation For Hyperthermia Systems

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has obtained approval to market its hyperthermia systems in the Russian Federation. The Company's hyperthermia products will be marketed in Russia by MSM-Medimpex (Medimpex), a premier distributor of sophisticated oncology medical devices in Russia. Medimpex also distributes radiation therapy devices from Electa, which dominate the oncology market in Russia. The marketing approval covers all BSD-2000 Hyperthermia System configurations and the BSD-500 Hyperthermia System.

Russia has a population of 149 million and is a potentially lucrative market for medical device companies. In 2007, the Russian market for medical devices and related supplies totaled $1.8 billion, which puts the Russia market among the top 20 in the world. Around 80% of the medical equipment market in Russia is supplied by non-Russian manufacturers. The United States, Germany, and Japan account for more than half of all imports.

Devices can only be imported into the Russian Federation after a Company passes testing conducted by a local testing body that demonstrates product safety and effectiveness. The registration of medical devices and medical equipment in Russia is very challenging. Thus, obtaining approval in Russia is a significant milestone for BSD.

“We are excited to establish a business relationship with one of the leading oncology product distributors in the Russian Federation,” stated Harold R. Wolcott, President of BSD Medical. “Even though hyperthermia has been utilized in Russia for many years, there is a lack of commercially available sophisticated systems. Cancer treatments in Russia are usually delivered in large, centralized, sophisticated, cancer treatment centers. These centers provide a unique marketing opportunity for BSD. The Company believes that Russia represents a significant marketing opportunity for the Company's hyperthermia products.”

About BSD Medical Corporation

BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy, which is delivered using focused radiofrequency (RF) and microwave energy. BSD’s product lines include both hyperthermia and ablation treatment systems. BSD’s hyperthermia cancer treatment systems, which have been in use for several years in the United States, Europe and Asia, are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. BSD’s microwave ablation system has been developed as a stand-alone therapy to employ precision-guided microwave energy to ablate (destroy) soft tissue. The Company has developed extensive intellectual property, multiple products in the market and established distribution in the United States, Europe and Asia. Certain of the Company’s products have received regulatory approvals and clearances in the United States, Europe and China. For further information visit BSD Medical's website at

Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,778.37 -11.82 -0.07%
S&P 500 1,976.44 -3.48 -0.18%
NASDAQ 4,728.8240 -19.5370 -0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs